These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 637486)
1. On the mechanism of corticosteroid-induced ocular hypertension. Godel V; Regenbogen L; Stein R Ann Ophthalmol; 1978 Feb; 10(2):191-6. PubMed ID: 637486 [No Abstract] [Full Text] [Related]
2. [Considerations on medical treatment with hyaluronidase in ocular hypertension caused by cortisone]. Quaranta CA; Marinosci F; Missiroli A Boll Ocul; 1967 Jun; 46(6):435-53. PubMed ID: 5614463 [No Abstract] [Full Text] [Related]
3. The long-acting Ocusert-pilocarpine system in the management of glaucoma. Lee P; Shen Y; Eberle M Invest Ophthalmol; 1975 Jan; 14(1):43-6. PubMed ID: 1110136 [TBL] [Abstract][Full Text] [Related]
5. Comparison of pilocarpine and echothiophate iodide in open-angle glaucoma. Harris LS Ann Ophthalmol; 1972 Sep; 4(9):736-9. PubMed ID: 5056919 [No Abstract] [Full Text] [Related]
6. Cataracts and primary open-angle glaucoma: the effect of uncomplicated cataract extraction on glaucoma control. Bigger JF; Becker B Trans Am Acad Ophthalmol Otolaryngol; 1971; 75(2):260-72. PubMed ID: 4933971 [No Abstract] [Full Text] [Related]
7. A comparison of pilocarpine hydrochloride and epinephrine bitartrate. Brounley DW Ann Ophthalmol; 1971 Sep; 3(9):970-3 passim. PubMed ID: 5163788 [No Abstract] [Full Text] [Related]
8. Aqueous dynamics of pilocarpine-treated eyes. The influence of topically applied epinephrine. Harris LS; Mittag TW; Galin MA Arch Ophthalmol; 1971 Jul; 86(1):1-4. PubMed ID: 5561378 [No Abstract] [Full Text] [Related]
10. EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. II. THE EFFECT OF DEXAMETHASONE IN THE GLAUCOMATOUS EYE. ARMALY MF Arch Ophthalmol; 1963 Oct; 70():492-9. PubMed ID: 14078871 [No Abstract] [Full Text] [Related]
11. Influence of drugs on aqueous flow in chronic simple glaucoma. Avasthi P; Sharma SD; Luthra MC Int Surg; 1968 Jun; 49(6):582-7. PubMed ID: 5657255 [No Abstract] [Full Text] [Related]
12. Medical management of glaucoma. Indian J Ophthalmol; 1983 Mar; 31(2):95-7. PubMed ID: 6662579 [No Abstract] [Full Text] [Related]
13. Topical adrenergic potentiators in primary open-angle glaucoma. Kitazawa Y Am J Ophthalmol; 1972 Oct; 74(4):588-93. PubMed ID: 4403873 [No Abstract] [Full Text] [Related]
14. [The effect of a 1 per cent adrenalin borate, pilocarpine and a combination of both drugs in glaucoma]. Duzanec Z; Leydhecker W Klin Monbl Augenheilkd; 1967; 151(6):877-81. PubMed ID: 5592981 [No Abstract] [Full Text] [Related]
15. Norepinephrine in treatment of ocular hypertension and glaucoma. Pollack IP; Rossi H Arch Ophthalmol; 1975 Mar; 93(3):173-7. PubMed ID: 1138682 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Christiansen GA; Nau CB; McLaren JW; Johnson DH Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319 [TBL] [Abstract][Full Text] [Related]
17. [Bivalent glaucoma therapy with pilocarpine and adrenaline - advantages of the combination piladren (author's transl)]. Unterkircher K Klin Monbl Augenheilkd; 1976 Oct; 169(4):534-7. PubMed ID: 792560 [TBL] [Abstract][Full Text] [Related]
18. Prolonged release medication in the treatment of eye disease. Lerman S Isr J Med Sci; 1972; 8(8):1402-5. PubMed ID: 4647794 [No Abstract] [Full Text] [Related]
19. Principles of medical management in chronic open angle glaucoma. Sugar HS Ann Ophthalmol; 1971 Jun; 3(6):579-86. PubMed ID: 5164431 [No Abstract] [Full Text] [Related]